The global high content screening (HCS) industry is poised for substantial growth, surpassing USD 1.7 billion in 2023. With a projected compound annual growth rate (CAGR) of 5.8%, the market is anticipated to reach approximately USD 3 billion by 2033. Market Growth Drivers Rising Pharmaceutical and Biotech Investments: The growing focus on drug discovery and development …